Affordable Access

deepdyve-link
Publisher Website

Knock-down of PSAT1 Enhances Sensitivity of NSCLC Cells to Glutamine-limiting Conditions.

Authors
  • Jin, Hyeon-Ok1
  • Hong, Sung-Eun2
  • Kim, Ji-Young3
  • Jang, Se-Kyeong2
  • Kim, Young-Sun3
  • Sim, Ju-Hee3
  • Oh, Ac-Chin4
  • Kim, Heyjin4
  • Hong, Young Jun4
  • Lee, Jin-Kyung3, 4
  • Park, In-Chul5
  • 1 KIRAMS Radiation Biobank, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea [email protected] [email protected] , (North Korea)
  • 2 Division of Fusion Radiology Research, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea. , (North Korea)
  • 3 KIRAMS Radiation Biobank, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea. , (North Korea)
  • 4 Department of Laboratory Medicine, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea. , (North Korea)
  • 5 Division of Fusion Radiology Research, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea [email protected] [email protected] , (North Korea)
Type
Published Article
Journal
Anticancer Research
Publisher
International Institute of Anticancer Research
Publication Date
Dec 01, 2019
Volume
39
Issue
12
Pages
6723–6730
Identifiers
DOI: 10.21873/anticanres.13887
PMID: 31810937
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Phosphoserine aminotransferase 1 (PSAT1) is an enzyme implicated in serine biosynthesis, and its overexpression has been linked to cancer cell proliferation. Therefore, targeting PSAT1 is considered to be an anticancer strategy. The viability of non-small cell lung cancer (NSCLC) cells was measured by MTT assay. Protein and mRNA expression were determined by western blot and reverse transcription polymerase chain reaction, respectively. Glutamine-limiting conditions were generated through glutamine deprivation or CB-839 treatment, which induced PSAT1 expression in NSCLC cells. PSAT1 expression induced by glutamine-limiting conditions was regulated by activating transcription factor 4. Knock-down of PSAT1 enhanced the sensitivity of NSCLC cells to glutamine-limiting conditions. Interestingly, ionizing radiation induced PSAT1 expression, and knocking down PSAT1 increased cell sensitivity to ionizing radiation. Inhibiting PSAT1 might aid in the treatment of lung cancer, and PSAT1 may be a therapeutic target for lung cancer. Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Report this publication

Statistics

Seen <100 times